(Q40410682)

20 September 2017

title

A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer (English)

1 reference

20 September 2017

0 references

0 references

5

1 reference

20 September 2017

3

Levon Abrahamyan

1 reference

20 September 2017

Kimberly Hu

1

1 reference

20 September 2017

Jean-Francois Clément

2

1 reference

20 September 2017

Klaus Strebel

4

1 reference

20 September 2017

Lawrence Kleiman

6

1 reference

20 September 2017

Andrew J Mouland

7

1 reference

20 September 2017

publication date

1 September 2005

1 reference

Journal of Virological Methods

20 September 2017

published in

1 reference

20 September 2017

volume

128

1 reference

20 September 2017

issue

1-2

1 reference

20 September 2017

page(s)

93-103

1 reference

Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor

20 September 2017

cites work

1 reference

12 December 2020

Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.

1 reference

12 December 2020

Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites.

1 reference

12 December 2020

High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/nucleocapsid processing site

1 reference

12 December 2020

Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein

1 reference

12 December 2020

The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRS).

1 reference

12 December 2020

Development of a microtiter plate fluorescent assay for inhibition studies on the HTLV-1 and HIV-1 proteinases

1 reference

12 December 2020

Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer

1 reference

12 December 2020

Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation

1 reference

12 December 2020

A late role for the association of hnRNP A2 with the HIV-1 hnRNP A2 response elements in genomic RNA, Gag, and Vpr localization

1 reference

12 December 2020

Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection

1 reference

12 December 2020

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective

1 reference

12 December 2020

Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers.

1 reference

12 December 2020

Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer

1 reference

12 December 2020

A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins

1 reference

12 December 2020

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor

1 reference

12 December 2020

The tRNALys packaging complex in HIV-1

1 reference

12 December 2020

Oligomerization of transcriptional intermediary factor 1 regulators and interaction with ZNF74 nuclear matrix protein revealed by bioluminescence resonance energy transfer in living cells

1 reference

12 December 2020

Antiviral drugs in current clinical use.

1 reference

12 December 2020

Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity

1 reference

12 December 2020

Enzyme activity--it's all about image

1 reference

12 December 2020

Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors

1 reference

12 December 2020

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

1 reference

12 December 2020

Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression

1 reference

12 December 2020

A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells

1 reference

12 December 2020

Real-time monitoring of ubiquitination in living cells by BRET.

1 reference

12 December 2020

Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2

1 reference

12 December 2020

Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing

1 reference

12 December 2020

Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process

1 reference

12 December 2020

Hypophosphorylation of poly(A) polymerase and increased polyadenylation activity are associated with human immunodeficiency virus type 1 Vpr expression

1 reference

12 December 2020

Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region

1 reference

12 December 2020

Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression

1 reference

12 December 2020

Primer tRNA3Lys on the viral genome exists in unextended and two-base extended forms within mature human immunodeficiency virus type 1.

1 reference

12 December 2020

Role of Vif in stability of the human immunodeficiency virus type 1 core

1 reference

12 December 2020

The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly

1 reference

12 December 2020

Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles

1 reference

12 December 2020

Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases

1 reference

12 December 2020

Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.

1 reference

12 December 2020

Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer

1 reference

12 December 2020

The regulation of sequential processing of HIV-1 Gag by the viral protease

1 reference

12 December 2020

Cleavage of p15 protein in vitro by human immunodeficiency virus type 1 protease is RNA dependent

1 reference

12 December 2020

The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation

1 reference

12 December 2020

Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation

1 reference

12 December 2020

Bioluminescence and chemiluminescence in drug screening

1 reference

12 December 2020

The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective

1 reference

12 December 2020

10.1016/J.JVIROMET.2005.04.012

Identifiers

DOI

1 reference

20 September 2017

0 references

1 reference